Format

Send to

Choose Destination
Med Clin (Barc). 2010 Nov 13;135(14):665-70. doi: 10.1016/j.medcli.2009.10.017. Epub 2009 Dec 31.

[Growth hormone revisited].

[Article in Spanish]

Author information

1
Departamento de Fisiología, Facultad de Medicina, Santiago de Compostela, España; Centro Médico Proyecto Foltra, Cacheiras, Teo, A Coruña, España. jesus.devesa@usc.es

Abstract

Growth hormone (GH) is a pleiotropic hormone, expressed at pituitary and peripheral level, which plays a number of different roles far beyond of those classically described. Among these effects it is remarkable the neurotropic role of GH: the hormone increases the proliferation and survival of neural precursors in response to neurological injuries. At the cardiovascular level, GH improves the lipidic profile and decreases the factors of cardiac risk; the hormone recovers the endothelial function, improves the cardiac function and potentiates revascularisation in ischemic territories. Differently to that occurring with autocrine GH, exogenous GH administration does not seem to be related to oncogenesis. According to its effects, there are multiple potential clinical applications of GH: acute treatment of brain injury, due to its antiapoptotic effect; central or peripheral neural regeneration; acute treatment of perinatal anoxia, prevention cerebral palsy; revascularisation of ischemic areas; decrease of the time of bone consolidation after a bone fracture; and torpid ulcer healing.

PMID:
20045134
DOI:
10.1016/j.medcli.2009.10.017
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Ediciones Doyma, S.L.
Loading ...
Support Center